The initial focus will be on Zika and chikingunya, and will leverage iBio's antigen and antibody manufacturing capabilities for product prototype development.
The company is now commencing a trial of the test platform in 250 patients to generate more data while it considers how to best commercialize it.
They have begun field testing near-infrared spectroscopy as an alternative to PCR and ELISA for routine pathogen screening in mosquitoes.
The company has partnered with several major medical centers to recruit several thousand subjects to compare its test to current mainstays.
The platform, which its developers said is well suited to point-of-care testing, uses fluorescent polymers to distinguish between samples from cases and controls.
To detect clinically relevant levels, the magneto-optic system measured magnetic nanocrystals in rabbit blood created by the malaria parasite.
Years after several high-profile failures, activity is up among researchers looking to multi-analyte protein assays for monitoring and detection of the disease.
Researchers at the University of Washington have developed a diagnostic platform that leverages the lateral flow immunoassay concept using quantum dots, a mobile phone, and an ultraviolet light-emitting diode.
In a study, Medical Research Council scientists demonstrated that a test that uses flow cytometry and looks for the CD63 protein in mast cells had 98 percent specificity.
Their machine learning technology coupled with digital holography produced an 84 percent success rate in predicting canine responses to chemotherapy.